[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100552527":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":27,"centralContacts":32,"locations":41,"responsibleParty":75,"collaborators":79,"id":83,"slug":24,"hasResults":84,"nctId":85,"briefTitle":86,"officialTitle":87,"acronym":24,"eligibilityCriteria":88,"healthyVolunteers":84,"sex":89,"minAge":90,"maxAge":91,"enrollmentInfo":92,"targetDuration":24,"studyType":95,"phases":96,"briefSummary":99,"conditions":100,"keywords":102,"overallStatus":43,"whyStopped":24,"lastUpdateSubmitDate":106,"lastUpdatePostDateStruct":107,"startDateStruct":110,"completionDateStruct":112,"leadSponsor":114,"locationsCount":115},{"fullName":5,"class":6},"Universiti Sains Malaysia","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Postbiotic","EXPERIMENTAL","Postbiotic at 1g\u002Fday as an adjunct treatment against vaginal candidiasis in women for 4-weeks",[13],"Device: Postbiotic",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","Placebo at 1g\u002Fday as an adjunct treatment against vaginal candidiasis in women for 4-weeks",[19],"Device: Placebo",[21,25],{"type":22,"name":9,"description":11,"armGroupLabels":23,"otherNames":24},"DEVICE",[9],null,{"type":22,"name":15,"description":17,"armGroupLabels":26,"otherNames":24},[15],[28],{"name":29,"affiliation":30,"role":31},"Sumita Bhatia, MD","Sumita Hospital","PRINCIPAL_INVESTIGATOR",[33,37],{"name":29,"role":34,"phone":35,"phoneExt":24,"email":36},"CONTACT","91923569755","bhatiadrsumita@gmail.com",{"name":38,"role":34,"phone":39,"phoneExt":24,"email":40},"Min Tze Liong, PhD","604 653 2114","mintze.liong@usm.my",[42,60],{"facility":30,"status":43,"city":44,"state":45,"zip":46,"country":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"RECRUITING","Lucknow","Aliganj","226024","India",{"type":49,"coordinates":50},"Point",[51,52],80.92313,26.83928,{"lat":52,"lon":51},[55,56,59],{"name":29,"role":34,"phone":35,"phoneExt":24,"email":36},{"name":57,"role":58,"phone":24,"phoneExt":24,"email":24},"Shandra Devi Balasubramaniam, PhD","SUB_INVESTIGATOR",{"name":38,"role":58,"phone":24,"phoneExt":24,"email":24},{"facility":61,"status":62,"city":63,"state":64,"zip":24,"country":65,"cosmosGeoPoint":66,"geoPoint":70,"contacts":71},"AIMST University","NOT_YET_RECRUITING","Bedong","Kedah","Malaysia",{"type":49,"coordinates":67},[68,69],100.50876,5.72743,{"lat":69,"lon":68},[72],{"name":57,"role":34,"phone":73,"phoneExt":24,"email":74},"6044298000","shandradevi@aimst.edu.my",{"type":76,"investigatorFullName":77,"investigatorTitle":78,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"SPONSOR_INVESTIGATOR","Min-Tze LIONG","Professor",[80,82],{"name":61,"class":81},"UNKNOWN",{"name":30,"class":81},"100552527",false,"NCT06474247","Postbiotic as Adjunct Treatment for Vaginal Candidiasis","Use of Postbiotic as Adjunct Treatment for Vaginal Candidiasis in Women","Inclusion criteria\n\n* Women who are sexually active\n* Confirmed with candidiasis as confirmed via clinical observations which include creamy whitish vaginal discharge and vulva-vaginal itchiness\n* Willing to commit throughout the experiment\n\nExclusion criteria\n\n* Long term medication (6 months or more) for any illnesses\n* Pregnant\n* Menopaused\n* Uterus and\u002For cervix removed\n* Cervical intraepithelial neoplasia\n* Vaginal suppository treatments within 4-weeks prior to entering the study\n* Oral medication for vaginal illnesses or any vaginal therapy such as hormones and estrogen within 4-weeks prior to entering the study\n* Have used vaginal estrogen cream, ring or tablet within 4-weeks prior to entering the study\n* Have used vaginal moisturizers, lubricants or homeopathic preparations within 4-weeks prior to entering the study\n* Have used spermicide agent within 4-weeks prior to entering the study\n* Have pelvic or any gynecologic surgery 6-months prior to entering the study","FEMALE","18 Years","81 Years",{"count":93,"type":94},118,"ESTIMATED","INTERVENTIONAL",[97,98],"PHASE2","PHASE3","This project aims to study the efficacy of intravaginal administration of postbiotic at 1g\u002Fday as an adjunct treatment against vaginal candidiasis in women for 4-weeks compared to placebo.",[101],"Vaginal Candidiasis",[103,104,105],"probiotic","postbiotic","vaginal candidiasis","2024-07-02",{"date":108,"type":109},"2024-07-05","ACTUAL",{"date":111,"type":109},"2024-06-02",{"date":113,"type":94},"2025-06-02",{"name":77,"class":6},2]